| pubmed-article:2123430 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2123430 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:2123430 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:2123430 | lifeskim:mentions | umls-concept:C0011849 | lld:lifeskim |
| pubmed-article:2123430 | lifeskim:mentions | umls-concept:C0597198 | lld:lifeskim |
| pubmed-article:2123430 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2123430 | lifeskim:mentions | umls-concept:C2348243 | lld:lifeskim |
| pubmed-article:2123430 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2123430 | pubmed:dateCreated | 1991-1-14 | lld:pubmed |
| pubmed-article:2123430 | pubmed:abstractText | Because some aldose reductase inhibitor studies have demonstrated clinical improvement in scored neurological signs and symptoms of diabetic neuropathy, a prospective study of the effect on cardiovascular performance of sorbinil 250 mg/day for 12 months was conducted on patients with diabetic autonomic neuropathy who were free of atherosclerotic coronary artery disease and/or cardiomyopathy. After 1 year of treatment, the study group (n = 14) demonstrated significant improvement in both the resting cardiac output (P = 0.02), and the maximal cardiac output (P = 0.03). This observation suggests that the use of an aldose reductase inhibitor may be useful in treating suboptimal cardiovascular performance in patients with diabetic cardiac autonomic neuropathy. | lld:pubmed |
| pubmed-article:2123430 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2123430 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2123430 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2123430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2123430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2123430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2123430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2123430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2123430 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2123430 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2123430 | pubmed:issn | 0168-8227 | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:SamolsEE | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:PfeiferM AMA | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:FellRR | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:CyrusJJ | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:SniderH LHL | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:RoyT MTM | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:BroadstoneV... | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:PetersonH RHR | lld:pubmed |
| pubmed-article:2123430 | pubmed:author | pubmed-author:RothchildA... | lld:pubmed |
| pubmed-article:2123430 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2123430 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:2123430 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2123430 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2123430 | pubmed:pagination | 91-7 | lld:pubmed |
| pubmed-article:2123430 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:meshHeading | pubmed-meshheading:2123430-... | lld:pubmed |
| pubmed-article:2123430 | pubmed:articleTitle | The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus. | lld:pubmed |
| pubmed-article:2123430 | pubmed:affiliation | Diabetic Research Unit, Louisville Veterans Administration Medical Center, KY. | lld:pubmed |
| pubmed-article:2123430 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2123430 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2123430 | lld:pubmed |
